Anal Squamous Cell Carcinoma

Oncology
1
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Novartis
NovartisBASEL, Switzerland
1 program
1
Regorafenib in combination with TislelizumabPhase 2Monoclonal Antibody
Varian Medical Systems
1 program
Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and DeliveryN/A1 trial
Active Trials
NCT05838391RecruitingEst. Dec 2028

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
Varian Medical SystemsArtificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery

Clinical Trials (1)

NCT05838391Varian Medical SystemsArtificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery

Adaptive Radiation in Anal Cancer

Start: May 2023Est. completion: Dec 2028
N/ARecruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space